Logo image
Human–mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect
Journal article   Open access   Peer reviewed

Human–mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect

Qian Dong, Lynda S Ostedgaard, Christopher Rogers, Daniel W Vermeer, Yuping Zhang and Michael J Welsh
Proceedings of the National Academy of Sciences - PNAS, Vol.109(3), pp.917-922
01/17/2012
DOI: 10.1073/pnas.1120065109
PMCID: PMC3271874
PMID: 22210114
url
https://doi.org/10.1073/pnas.1120065109View
Published (Version of record) Open Access

Abstract

The Δ F508 mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene is the most common cause of cystic fibrosis. The mutation disrupts biosynthetic processing, reduces channel opening rate, and decreases protein lifetime. In contrast to human CFTR (hCFTR)-ΔF508, mouse CFTR-ΔF508 is partially processed to the cell surface, although it exhibits a functional defect similar to hCFTR-ΔF508. To explore Δ F508 abnormalities, we generated human–mouse chimeric channels. Substituting mouse nucleotide-binding domain-1 (mNBD1) into hCFTR partially rescued the ΔF508-induced maturation defect, and substituting mouse membrane-spanning domain-2 or its intracellular loops (ICLs) into hCFTR prevented further Δ F508 -induced gating defects. The protective effect of the mouse ICLs was reverted by inserting mouse NBDs. Our results indicate that the Δ F508 mutation affects maturation and gating via distinct regions of the protein; maturation of CFTR-ΔF508 depends on NBD1, and the Δ F508 -induced gating defect depends on the interaction between the membrane-spanning domain-2 ICLs and the NBDs. These appear to be distinct processes, because none of the chimeras repaired both defects. This distinction was exemplified by the I539T mutation, which improved CFTR-ΔF508 processing but worsened the gating defect. Our results, together with previous studies, suggest that many different NBD1 modifications improve CFTR-ΔF508 maturation and that the effect of modifications can be additive. Thus, it might be possible to enhance processing by targeting several different regions of the domain or by targeting a network of CFTR-associated proteins. Because no one modification corrected both maturation and gating, perhaps more than a single agent will be required to correct all CFTR-ΔF508 defects.
Biological Sciences protein biosynthesis anion channel

Details

Metrics

Logo image